Nitrous oxide

Description

Nitrous Oxide USP is a non-flammable gas classified as an oxidizer (UN1070) with a CAS number of 10024-97-2. It is utilized in various medical applications due to its anesthetic and analgesic properties. The compound is characterized by its specific chemical properties and is subject to regulatory standards for safe handling and use in clinical settings.

Uses and Indications

Nitrous Oxide is indicated for use in clinical settings where its administration is deemed appropriate by a licensed practitioner. This drug should only be administered by or under the supervision of a healthcare professional who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the drug's indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrous Oxide administration, which may render it contraindicated in certain situations. There are no specific teratogenic or nonteratogenic effects documented for this drug.

Dosage and Administration

Administration of Nitrous Oxide may pose hazards or be contraindicated in certain situations. It is essential that this agent is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide.

The route of administration for Nitrous Oxide is via respiratory inhalation. Practitioners should ensure that the patient is adequately monitored throughout the procedure to manage any potential risks associated with its use.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where its use may pose a hazard to the patient. It is essential that Nitrous Oxide is administered only by or under the supervision of a licensed practitioner who possesses experience in its use and administration.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant hazards and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. The potential for rapid suffocation exists, and the gas can induce anesthetic effects. Additionally, exposure may lead to frostbite. Therefore, it is crucial to avoid inhalation of the gas and to ensure that it is stored and utilized in an environment with adequate ventilation. Precautions must be taken to keep oil and grease away from the gas, and only equipment that has been cleaned for oxygen and rated for cylinder pressure should be employed. Care should be taken to prevent liquid from contacting the eyes, skin, or clothing. The cylinder temperature must not exceed 52°C (125°F), and the valve should be opened slowly. It is essential to close the valve after each use and when the cylinder is empty. A backflow preventive device should be utilized in the piping, and all usage should comply with the Material Safety Data Sheet (MSDS).

In the event of inhalation, immediate first aid measures should be taken. The individual should be removed to fresh air, and if not breathing, artificial respiration should be administered. If breathing is difficult, supplemental oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, prompt medical treatment is necessary.

No specific laboratory tests are recommended for monitoring the use of Nitrous Oxide. However, healthcare professionals should remain vigilant and prepared to provide emergency medical assistance as needed.

Side Effects

Administration of Nitrous Oxide may pose significant hazards and is contraindicated in certain situations. It is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion, potentially leading to rapid suffocation. Additionally, it can induce anesthetic effects and may cause frostbite.

Common adverse reactions associated with Nitrous Oxide include anesthetic effects and frostbite. Participants in clinical settings have reported these reactions, emphasizing the need for careful monitoring during administration.

It is crucial for patients and healthcare providers to adhere to safety precautions when using Nitrous Oxide. This includes avoiding the inhalation of the gas, ensuring adequate ventilation during use, and keeping oil and grease away from the equipment. Equipment should be cleaned for oxygen use and rated for cylinder pressure to prevent accidents.

Furthermore, precautions should be taken to prevent liquid Nitrous Oxide from coming into contact with eyes, skin, or clothing. The cylinder temperature must not exceed 52°C (125°F), and valves should be opened slowly and closed after each use or when empty. A backflow preventive device should be utilized in the piping to enhance safety.

In the event of an adverse reaction, first aid measures should be implemented immediately. If inhaled, the individual should be removed to fresh air. If breathing has ceased, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. Medical assistance should be sought promptly in cases of frostbite. It is recommended to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for comprehensive safety information.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated in pediatric patients. It is essential that this agent is used only by or under the supervision of a licensed practitioner who has experience in the use and administration of Nitrous Oxide, particularly in pediatric populations. Caution is advised when considering its use in children, infants, and adolescents.

Geriatric Use

There is no specific information regarding the use of Nitrous Oxide in geriatric patients, including recommended age considerations, dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when administering this agent to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and adjusting treatment as necessary is advised, given the lack of targeted data for this population.

Pregnancy

Administration of Nitrous Oxide may pose potential risks during pregnancy and is considered hazardous or contraindicated. Healthcare professionals should exercise caution when prescribing this agent to pregnant patients, as the effects on fetal outcomes have not been fully established. It is advisable to evaluate the necessity of Nitrous Oxide in the context of the potential risks to both the mother and the developing fetus. Women of childbearing potential should be informed of these risks and the importance of discussing any plans for pregnancy with their healthcare provider prior to use.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for Nitrous Oxide. Therefore, the effects on breastfed infants and the excretion of Nitrous Oxide in breast milk remain undetermined. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this agent.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

Overdosage of Nitrous Oxide may lead to significant anesthetic effects, which can pose serious risks to the individual. It is crucial for healthcare professionals to recognize the potential hazards associated with the administration of Nitrous Oxide, as it may be contraindicated in certain situations.

In the event of an overdosage, immediate action is required. The first step is to remove the affected individual to an area with fresh air to mitigate the effects of the gas. If the individual is not breathing, it is imperative to provide artificial respiration promptly. Should the individual experience difficulty in breathing, supplemental oxygen should be administered to ensure adequate oxygenation.

Furthermore, it is essential to call a physician for further assistance and guidance on managing the situation effectively. Prompt medical intervention is critical to address any complications arising from Nitrous Oxide overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards or be contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the following warning to patients: Nitrous Oxide is a high-pressure oxidizing liquid and gas that vigorously accelerates combustion, can cause rapid suffocation, and may induce anesthetic effects. Additionally, it has the potential to cause frostbite. Patients should be instructed to avoid breathing the gas and to ensure that the environment is adequately ventilated during use.

It is critical to keep oil and grease away from the area where Nitrous Oxide is stored and used. Patients should only utilize equipment that has been cleaned for oxygen and is rated for cylinder pressure. They must be cautioned against allowing liquid Nitrous Oxide to come into contact with their eyes, skin, or clothing. Furthermore, the cylinder temperature should not exceed 52°C (125°F), and the valve should be opened slowly. After each use and when the cylinder is empty, the valve should be closed. A backflow preventive device should be employed in the piping to ensure safety.

Patients should be informed to use Nitrous Oxide in accordance with the Material Safety Data Sheet (MSDS). In the event of inhalation, they should be removed to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. It is important to call a physician for further assistance. In cases of frostbite, patients should seek medical treatment without delay.

Storage and Handling

The product is supplied in a manner that ensures safe handling and effective use. It is essential to store and utilize the product in an area with adequate ventilation to prevent the accumulation of potentially harmful gases. Care should be taken to keep oil and grease away from the gas to avoid any hazardous reactions.

The equipment used must be specifically cleaned for oxygen service and rated for the cylinder pressure to ensure safety during operation. It is critical to monitor the cylinder temperature, which should not exceed 52°C (125°F). When opening the valve, it should be done slowly to prevent sudden pressure changes. After each use, and when the cylinder is empty, the valve must be securely closed.

To maintain safety in the piping system, a backflow preventive device should be employed. All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure compliance with safety protocols and guidelines.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Welding & Therapy Service, Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)